Raymond James Financial Inc. Takes Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Raymond James Financial Inc. bought a new position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 49,015 shares of the company’s stock, valued at approximately $1,564,000. A number of other institutional investors and hedge funds […]
Raymond James Financial Inc. bought a new position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 49,015 shares of the company’s stock, valued at approximately $1,564,000. A number of other institutional investors and hedge funds […]
